ACUTE PYELONEPHRITIS
Clinical trials for ACUTE PYELONEPHRITIS explained in plain language.
Never miss a new study
Get alerted when new ACUTE PYELONEPHRITIS trials appear
Sign up with your email to follow new studies for ACUTE PYELONEPHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibiotic combo shows promise against tough UTIs
Disease control CompletedThis study tested a new antibiotic combination, cefepime-zidebactam, against a standard antibiotic (meropenem) in adults hospitalized with complicated urinary tract infections or kidney infections. About 530 participants received either the new drug or the standard one for 7 to 1…
Matched conditions: ACUTE PYELONEPHRITIS
Phase: PHASE3 • Sponsor: Wockhardt • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New antibiotic cocktail takes on superbugs in phase 3 trial
Disease control CompletedThis study tested two new antibiotic combinations (cefepime/nacubactam and aztreonam/nacubactam) against the best available treatments for adults with serious infections like urinary tract infections, pneumonia, and abdominal infections caused by carbapenem-resistant bacteria. Th…
Matched conditions: ACUTE PYELONEPHRITIS
Phase: PHASE3 • Sponsor: Meiji Seika Pharma Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Pill power: oral antibiotic could replace IV for tough UTIs
Disease control CompletedThis study tested an oral antibiotic (tebipenem pivoxil hydrobromide) against a standard IV antibiotic in 1,690 hospitalized adults with complicated urinary tract infections or kidney infections. The goal was to see if the oral pill works as well as the IV treatment in curing the…
Matched conditions: ACUTE PYELONEPHRITIS
Phase: PHASE3 • Sponsor: Spero Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New antibiotic cocktails take on tough UTIs and kidney infections
Disease control CompletedThis phase 3 trial tested two new antibiotic combinations—cefepime/nacubactam and aztreonam/nacubactam—against a standard antibiotic (imipenem/cilastatin) in 614 adults with complicated urinary tract infections or acute kidney infections. The goal was to see if the new combos are…
Matched conditions: ACUTE PYELONEPHRITIS
Phase: PHASE3 • Sponsor: Meiji Seika Pharma Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC